Vaccination with autologous myeloblasts admixed with GM-K562 cells in patients with advanced MDS or AML after allogeneic HSCT

We report a clinical trial testing vaccination of autologous myeloblasts admixed with granulocyte-macrophage colony-stimulating factor secreting K562 cells after allogeneic hematopoietic stem cell transplantation (HSCT). Patients with myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) wi...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Blood Adv
Asıl Yazarlar: Ho, Vincent T., Kim, Haesook T., Bavli, Natalie, Mihm, Martin, Pozdnyakova, Olga, Piesche, Matthias, Daley, Heather, Reynolds, Carol, Souders, Nicholas C., Cutler, Corey, Koreth, John, Alyea, Edwin P., Antin, Joseph H., Ritz, Jerome, Dranoff, Glenn, Soiffer, Robert J.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Hematology 2017
Konular:
Transplantation
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5737123/
https://ncbi.nlm.nih.gov/pubmed/29296875
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2017009084
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller